Inter-mouse strain differences in thein vivoanti-CD3 induced cytokine release
Open Access
- 1 December 1991
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 86 (3) , 537-543
- https://doi.org/10.1111/j.1365-2249.1991.tb02966.x
Abstract
Triggering of the CD3 molecule by in vivo injection of the hamster anti-murine CD3 monoclonal antibody 145-2C11 in adult BALB/c mice leads to massive although transient T cell activation. High levels of tumour necrosis factor (TNF), interferon-gamma (IFN-γ), IL-2, IL-3 and IL-6 are released into the circulation 1 to 8 h after a single 10 μg 145-2C11 i.v. injection. This release induces an impressive self-limited physical reaction associating hypothermia, hypomotility (as assessed by actimetry), diarrhoea, piloerection and even death when high doses (a single dose of > 100 μg/mouse injection) are administered. In vivo injection of 145-2C11 to other selected mouse strains, namely NZW, CBA/J and C3H/HeJ, induced both different cytokine release patterns and sickness. 145-2C11 induced significant release of TNF and IL-2 in all four strains. At variance. IFN-γ was only detected in BALB/c mice sera which, in terms of physical reaction (hypothermia and hypomotility) were the most affected. Higher and long-lasting circulating 1L-3/GM-CSF levels were present in CBA/J sera, correlating with a later recovery. These results underline heterogeneity in the in vivo cell activation pattern among different mouse strains, when triggering T lymphocytes via the CD3/Ti molecule as compared to exclusive targeting of monocyte/macrophages by means of lipopolysaccharide.Keywords
This publication has 26 references indexed in Scilit:
- REDUCTION OF MORBIDITY AND CYTOKINE RELEASE IN ANTI-CD3 MoAb-TREATED MICE BY CORTICOSTEROIDSTransplantation, 1990
- Cytokine‐related syndrome following injection of anti‐CD3 monoclonal antibody: Further evidence for transient in vivo T cell activationEuropean Journal of Immunology, 1990
- Hypothermia and hypoglycemia induced by anti‐CD3 monoclonal antibody in mice: Role of tumor necrosis factorEuropean Journal of Immunology, 1990
- Systemic Reaction to the Anti–T-Cell Monoclonal Antibody OKT3 in Relation to Serum Levels of Tumor Necrosis Factor and Interferon-αNew England Journal of Medicine, 1989
- Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.The Journal of Experimental Medicine, 1988
- Tumour necrosis factor-α in murine autoimmune 'lupus' nephritisNature, 1988
- Control of Cachectin (Tumor Necrosis Factor) Synthesis: Mechanisms of Endotoxin ResistanceScience, 1986
- Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferonNature, 1985
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- Genetic Control of Leucocyte Responses to EndotoxinNature, 1968